The BRAF Kinase Inhibitors Market involves drugs that act as targeted therapy against cancers caused due to mutations in BRAF genes. BRAF kinase inhibitors work by blocking the BRAF proteins from working properly and inhibit tumor cell growth. Some key BRAF inhibitors include vemurafenib, dabrafenib and encorafenib. BRAF inhibitors are majorly used for treating melanoma skin cancer that has...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian